Overview of the Unfolded Protein Response
13th International Myeloma Workshop
632011
AnnHwee Lee, PhD
QuickTimeTM and a
decompressor
are needed to see this picture.
Harvard Medical School/School of Public
Health
Hallmark feature of plasma cell differentiation
Resting B cell
Active B cell
(Plasma cell)
1
Maturation of secretory and
transmembrane proteins
Lipid membrane biogenesis
Major calcium storage
UPR is activated by ER stress
Tunicamycin
Grp78
· Pharmacological
Tunicamycin, DTT, etc
Grp94
· Physiological
Secretory proteins (Immunoglobulins)
CHOP
ER stress ·Pathological
Misfolded proteins
RNA
UPR
Apoptosis Degradation
Transport
Folding
2
UPR signaling pathway Saccharomyces cerevisiae
DTT
PI
Inositol
SS
INO1
SH
SH
G6P
IRE1
UDPGlcNAc
Tunicamycin
Thapsigargin
Ca++
HAC1
BiP (Kar2p)
Protein folding
UPRE
INO1
Phospholipid biosynthesis
IRE1 : Nikawa J, Yamashita and S, Mol Microbiol., 1992
Mori K and J. Sambrook J, Cell, 1993
HAC1 : Cox J and Walter P, Cell, 1993
Mammalian UPR signaling pathway
PERK IRE1 ATF6
P
Proteolytic
eIF2
XBP1 mRNA
processing
Suppress
Protein
synthesis
ATF4
XBP1(S)
ATF6(N)
3
IRE1/XBP1 signaling pathway
Unfolded protein species
BiP
Luminal
ER membrane
P
P
IRE1
Cytosolic
Unfolded protein species
P
P
IRE1
Credle et al., Proc. Natl. Acad. Sci. USA. 2005
Zhou et al., Proc. Natl. Acad. Sci. USA. 2006
Lee et al., Cell. 2008
Korennykh, et al., Nature. 2009
Ali et al., EMBO 2011
IRE1/XBP1 signaling pathway
IRE1
Luminal
P
P
ER membrane
Cytosolic
Kinase
XBP1 mRNA
Endoribonuclease
XBP1s
4
Splicing of XBP1 mRNA by IRE1
C
C
GA
GA
U
G
C
G
C
C
C
C
U A
U A
C G
G C
C G
A U
A U
G C
C G
U A
G C
CUGC GACUAUGUA GGC
mRNA
er
Tm
Mark
+
29
826
200 bp
26 nt
29
U
1164
S
503 529
100 bp
29
826
bZIP
XBP1u
29
503/529
1164
bZIP
XBP1s
XBP1 is highly expressed in secretory organs
35000
Lacrimal gland
30000
25000
Pancreas
Salivary gland
Mammary gland
20000
15000
10000
5000
0
1
2
F
+
n
e
d
a
e
a
-
3
p
r
s
e
S
S
S
E
r
3
s
4
1
s
y
d
LH
LH
ne
f3
3
n
ex
tal
is
ies
lia
m
1
16
is
u
o
art
us
u
all
ey
nd
es
P
P
P
g
lia
n6
lb
ta
ch
tis
rd
K
C1
ME
an
n
d
itor
a+
g
p
m
r1+
rg
ir
n
lens
D-3
act
ito
g
en
u
ay5
ast
ary
tina
an
_
Ba
D4+
D8+
8
la
liver
b
leen
_cells
xP
row
lung
D4+
D8+
erus
gl
en
adder
bo
rrow
ellum
itar
ro
o
en
D
D8a
iatu
_
enit
he
mp
am
C
_0hrs
_1hrs
_7hrs
_cells
_1hr
_6hr
o
mi
uro2a
_
ay1
ay2
d
ov
creas
state
re
gl
tes
3T3-L
_Alum
l_zo
C2
o
b
_
ygdal
corne
an
kid
M
w_0hr
__l
lls_I
d
d
_
tu
ac
o
helium
l_cord
sp
oma
l_co
ut
ive_K
C
eyec
al
en
en
gen
icr
_C
_C
NK
_264_7
_
bl
ef
_C
ca
io
io
io
_
_
se_whit
al
_ma
eb
_B220+
str
ce4
r_B-cells
c1+g
o
al_g
h_nod
h
h
h
actating
ast
ig
ig
ne
nih_3T
ory
eocl
pan
pi
pl
pr
it
y_
lls__HSC
st
ative
ive_Alum
ina
W
o
am
ral_cort
pr
ry_b
rog
id_
id
id
t_g
_
u
epider
rog
p
th
ine_la
ine_sm
mI
rro
ro
m
ccumb
last
ina
ilica
g
H_10T1_2
p
land
_ce
sit
sit
ative
3
A
ose
en
ne
cer
b
_
_
o
o
o
im
w_2hr_L
w_6hr_L
m
nt
nt
p
last
last
ost
ep
b
o
o
g
arg
w_24h_L
ivar
C
R
ip
Br
S_t
S_t
S_t
st
_
e_SP
e_SP
T-cells_C
T-cells_C
ip
o
re
d
yelo
rsal
_V26_2_p
hip
ypo
est
est
cr
lymp
ma
P
P
P
_g
fact
eob
letal_muscle
sp
_ce
_CD4+CD8+
T-cells_f
b
cilia
ph
_
+a
+a
ad
ad
adr
rtex
cyt
l_ro
e_
llicula
h
int
la
rro
rro
rro
ry
_non-l
E
E
us_a
ol
eob
eob
ent
sal
cyt
cyt
um
7_ne
int
ma
7_p
7_p
ce
do
es_ma
ne
g
g
cyte_
ske
em
DP
7_ne
co
eloi
lin
fo
o
ma
ma
ost
m
st
o
o
_
lym
rsao
_
_line
cyt
ma
_
_
eri_L
eri_L
eri_L
land
ro
ost
ost
ig
e_
al
my
lasma
d
ym
ym
em
e_b
e_
ne
ne
mma
lls_I
lls_I
nucle
lls_GL
g
n
o
o
e_p
e_p
e_p
_g
l_p
th
th
lls_GL
B-cells_m
cells_
o
ic_p
stem
g
g
g
ma
ry
_ce
_ce
eryth
c_
ranulo_mono_p
ranulo
ha
ha
ha
ha
ymocyt
B-ce
ic_
p
e_b
e_b
st
st
B-cells_GL
B-cells_GL
cerebr
ritic_cells_m
rit
nic_st
g
g
e_b
B-ce
n
g
g
g
p
p
p
ega_
retina
th
common_
ritid
mma
end
yo
cro
ha
ha
ma
ma
d
end
ryo
d
ha
cro
cro
cro
m
br
b
p
p
p
ma
den
ma
ma
ma
ma
em
em
cro
cro
cro
ma
ma
ma
BIOGPS : http://biogps.gnf.org/
5
Role of XBP1 in development of secretory cells
Plasma cell
Pancreatic acinar cell
Paneth cell
Reimold et al, Nature, 2001
Lee et al, EMBO 2005
Kaser et al, Cell 2008
Severely impaired plasma cell generation in the
absence of XBP1 and greatly diminished
immunoglobulin
6
Induction and IRE1mediated splicing of XBP1
mRNA during plasma cell differentiation
LPS stimulation
Time (h):
0
244872
XBP1
actin
forward
26bp
XBP-1u
XBP-1s
reverse
XBP1s
Iwakoshi et al. Nat. Immunol. (2003)
Impaired immunoglobulin production from XBP1
deficient B cells
ES cells
XBP1-/-
Blastocyst
Rag2-/-
Lymphoid cells : XBP1-/-
Liver : Rag2-/-
Others : Mixture of Rag2-/- and XBP1-/-
Reimold et al., Nature, 2001
7
XBP1/ Rag chimeras fail to mount an
immune response
Reimold et al., Nature, 2001
UPR activation during plasma cell differentiation
PERK
IRE1
ATF6
ER
Block
P
eIF2
Protein
synthesis
ATF4
XBP1(S)
ATF6(N)
CHOP
Ma et al., Cell Stress and Chaperones (2010) 15:281293
Gass et al., Molecular Immunology 45 (2008) 10351043
Gass et al., J Biol Chem 277 (2002) 4904749054
Zhang et al., J Clin Invest. 115 (2005 ) 268281
Iwakoshi et al. Nat. Immunol. 4 (2003) 321329
8
XBP1 is essential for the development of
pancreatic acinar cells
WT
Xbp1/
LivXBP1
500 nm
500 nm
Lee et al. EMBO (2005)
XBP1 induces ER expansion and activates genes in protein
secretory pathway
XBP1
Phospholipid
Secretory Pathway
Synthesis
ER expansion
Translocation
Degradation
Sec61
EDEM
Derl1
Herp
Hrd1
Control
XBP1s
Mannosidase I
Folding
ERdj3
Grp78
p58IPK
Grp94
ERdj4
PDIs
Lee et al Mol. Cell. Biol. 2003
Shaffer et al Immunity 2004
Shaffer et al Immunity 2004
Sriburi et al J. Cell Biol 2004
Acosta-Alvear et al Mol. Cell 2007
9
Critical function of XBP1 in biogenesis
of cellular secretory machinery
Translocation
P
P
IRE1
Folding
Ig
Secretion
Zymogen
Degradation
XBP1 mRNA
ER expansion
XBP1s
Transcription
Is XBP1 also required for the survival of
myeloma cells?
What is the role of XBP1 in myeloma cells
treated with proteasome inhibitors
(Velcade)?
10
Proteasome inhibitors target IRE1/XBP1
· Inhibit IRE1 driven XBP1 mRNA splicing
· Stabilize XBP1u protein that acts as a dominant negative
stin
MG132 (1 µM)
132
acy
341
0124
8
16 hr
MG
PS
Lact
Tm :
+
++
+
XBP1s
XBP1u
XBP1s
XBP1u
Lee et al. PNAS (2003)
Inhibition of IRE1/XBP1 by proteasome inhibitors
correlates with apoptosis of myeloma cells
PI
90
ER stress
80
70
(%)
60
th
50
XBP1
40
l Dea
30
Cel
20
10
Protection
0
0
1
248 16 hr
MG132 (1 µM)
Apoptosis
11
Does XBP1 have a protective role in human
diseases associated with aggregation of
misfolded proteins?
Diseases associated with protein misfolding in the ER
Export
Degradation
Aggregation
No functional protein
Accumulation of misfolded protein
Cystic fibrosis
Alzheimer disease
Hereditary emphysema
Prion diseases
Hereditary hemochromatosis
Neonatal Diabetes
Duchenne muscular dystrophy
12
XBP1 does not affect prion pathogenesis
Hetz C. et.al. PNAS 2008;105:757762
©2008 by National Academy of Sciences
Delayed Amyotrophic Lateral Sclerosis by XBP1
deletion in brain
QuickTimeTM and a
decompressor
are needed to see this picture.
QuickTimeTM and a
decompressor
are needed to see this picture.
QuickTimeTM and a
decompressor
are needed to see this picture.
Hetz et al, Genes and Dev.(2010)
13
Role of UPR in other organ system
·Liver lipid metabolism
·Dual roles of IRE1
Low plasma lipid levels in XBP1 mice
4 weeks after Xbp1 deletion (polyIC injection)
WT, n = 12
Xbp1, n = 14
Lee et al. Science (2008)
14
Induction and hyperactivation of IRE1 by XBP1
deficiency in liver
1
1
1
1
1
1
1
1
1
p
p
p
p
p
p
p
p
p
WT
WT
WT
WT
Xb
Xb
Xb
Xb
Xb
WT
WT
WT
WT
Xb
Xb
Xb
Xb
phospho-IRE1
IRE1
Hsp90
7.5 µM PhosTag
Dual roles of IRE1/XBP1 UPR signaling in hepatic
lipid metabolism
IRE1
His.IRE1
His.IRE1
P
P
1
2
3
AAAA
AAAA
IRE1
AAAA
XBP1 mRNA
substrate
XBP1
mRNA
mRNA
RNA ligase
XBP1s
Ribonuclease
Splicing
Promote lipogenesis
Suppress lipogenesis
Degradation
15
Physiological functions of the UPR
ER signaling
ER stress
TLR activation macrophage
Phamacological (Tunicamycin, DTT)
High glucose liver
Physiological ER stress (secretory protein, ?)
Feedbak regulation
PERK
IRE1
ATF6
UPR/Stress response Development
Lipogenesis
Inflammtion
Protein
ER expansion
Lipogenic
Cytokines
folding homeostasis
ER chaperones in
enzymes
secretory cells
Acknowledgements
Harvard School of Public Health
Harvard Medical School
Laurie H.Glimcher
Gerald C. Chu
Andreas Reimold
Huib Ovaa
Neal Iwakoshi
Boaz Tirosh
Claudio Hetz
Hidde Ploegh
Derrick Todd
Fabio Martinon
National Institute of Health
Art L. Shaffer
Brigham and Women's Hospital
Louis M. Staudt
David E. Cohen
Erez F Scapa
RIKEN
Richard Blumberg
Takao Iwawaki
Arther Kaser
DanaFarber Cancer Institute
Kenneth C. Anderson
16